Australia markets close in 3 hours 58 minutes
  • ALL ORDS

    7,715.20
    +65.90 (+0.86%)
     
  • ASX 200

    7,405.60
    +63.00 (+0.86%)
     
  • AUD/USD

    0.7285
    +0.0024 (+0.33%)
     
  • OIL

    75.09
    +1.11 (+1.50%)
     
  • GOLD

    1,758.70
    +7.00 (+0.40%)
     
  • BTC-AUD

    60,750.99
    +2,545.04 (+4.37%)
     
  • CMC Crypto 200

    1,105.70
    +2.64 (+0.24%)
     
  • AUD/EUR

    0.6212
    +0.0020 (+0.33%)
     
  • AUD/NZD

    1.0365
    +0.0021 (+0.20%)
     
  • NZX 50

    13,297.97
    +38.42 (+0.29%)
     
  • NASDAQ

    15,329.68
    +13.08 (+0.09%)
     
  • FTSE

    7,051.48
    -26.87 (-0.38%)
     
  • Dow Jones

    34,798.00
    +33.20 (+0.10%)
     
  • DAX

    15,531.75
    -112.25 (-0.72%)
     
  • Hang Seng

    24,486.55
    +294.39 (+1.22%)
     
  • NIKKEI 225

    30,356.70
    +107.89 (+0.36%)
     

Senseonics Holdings, Inc. Schedules Second Quarter 2021 Earnings Release and Conference Call for August 9, 2021, at 4:30 p.m. Eastern Time

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

GERMANTOWN, Md., July 26, 2021--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its second quarter 2021 financial results after market close on Monday, August 9, 2021.

Management will hold a conference call to review the company’s second quarter 2021 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by navigating to "Investor Relations," and then "Events & Publications," and will be archived there for future reference. To listen to the conference call, please dial 1-888-317-6003 (US/Canada) or 1-412-317-6061 (International), passcode 4998185, approximately ten to five minutes prior to start time.

About Senseonics

Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of transformational glucose monitoring products designed to help people with diabetes confidently live their lives with ease. Senseonics' CGM Systems, Eversense® and Eversense® XL, include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210726005708/en/

Contacts

Senseonics Investor Contact
Lynn Lewis or Philip Taylor
Investor Relations
415-937-5406
investors@senseonics.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting